Johnson & Johnson’s US$1bn Investment for Vision & Eye Care
“By further strengthening our Vision operations in Jacksonville with next-generation manufacturing, packaging and distribution capabilities, we are enhancing the resilience of our US supply chain while helping more people see better and live better.
“This commitment reflects the confidence we have in our people, our technology and our more than 40-year legacy of advancing eye health globally.”
By investing in next-generation technologies, Johnson & Johnson is positioning itself to better serve the evolving needs of eye care consumers and healthcare professionals.
Strengthening healthcare supply chains
The Jacksonville expansion reflects Johnson & Johnson’s broader strategy to reinforce domestic healthcare manufacturing and distribution infrastructure.
Company leadership emphasised that advanced manufacturing in the US plays a critical role in delivering innovative, high-quality healthcare solutions for patients.
The investment forms part of Johnson & Johnson’s previously announced US$55bn commitment to US manufacturing, research and development and technology through early 2029.
Construction of the new facility is already underway, with full operations expected to begin in 2028.
“Johnson & Johnson’s commitment is a strong vote of confidence in Jacksonville, our workforce and our future,” says Mayor Donna Deegan.
